Wikidata

(Q65393821)

English

A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)

clinical trial

In more languages

Statements

title
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia (English)
0 references
start time
2 March 2016
0 references
end time
7 November 2018
0 references
number of participants
561
0 references
research site
Alkermes
0 references
minimum age
18 year
0 references
maximum age
55 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q65393821&oldid=1858436109"